A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality.

Park Y, Kim NH, Kwon TY, Kim SG. · 2018

Read A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. by Park Y, Kim NH, Kwon TY, Kim SG. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6233180.txt.

Introduction

Park and co-authors propose a new body fat index. Obesity raises the risk of heart and metabolic disease. Standard indexes such as BMI have known flaws. The team built a weight-adjusted waist index. The study appeared in Scientific Reports. It used a Korean nationwide cohort.

The index divides waist size by the square root of weight. Data covered more than 465,000 people. The team compared five indexes for disease and death risk. BMI best predicted new diabetes and hypertension. The new index best predicted death from heart disease. Its link to death rose in a straight line. Other indexes showed curved patterns that are harder to read. Pairing the new index with BMI worked best overall.

Catalog record

CREATORPark Y, Kim NH, Kwon TY, Kim SG.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6233180

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality By Yousung Park, Nam Hoon Kim, Tae Yeon Kwon, Sin Gon Kim Published in: Scientific Reports DOI: 10.1038/s41598-018-35073-4 ABSTRACT Abstract We propose a new anthropometric index, weight-adjusted-waist index (WWI), to assess adiposity by standardizing waist circumference (WC) for weight. WWI, calculated as WC (cm) divided by the square root of weight (kg) (cm/√kg), was measured from 465,629 subjects in the Korean nationwide cohort (2008–2013). Cox regression analysis was used to compare WWI with BMI, WC, waist-to-height ratio (WHtR), and a body shape index (ABSI) for cardiometabolic morbidity and mortality risk in diagnostic and prognostic prediction models. For incident hypertension, type 2 diabetes and cardiovascular disease (CVD), BMI had the strongest predictive power, followed by WWI and WC. However, WWI showed the best predictive performance for CVD mortality. Also, a linear positive association between adiposity indices and cardiovascular and all-cause mortality was only shown in WWI and ABSI, not BMI, WC and WHtR which showed inverse J-shaped patterns. In the test of joint effects of each index, WWI combined with BMI was the strongest in both diagnostic and prognostic models. WWI is a unique adiposity index that shows linear positive association with both cardiometabolic morbidity and mortality. It also predicts incident cardiometabolic disease, cardiovascular and all-cause mortality risk with excellence in predictive power, especially when combined with BMI. INTRODUCTION Obesity, defined as excess body fat, is a well-known risk factor for various chronic diseases including hypertension, type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and cardiovascular disease (CVD)1. Body mass index (BMI) is the most widely used measure of obesity. The prevalence of obesity, defined as a high BMI, has been increasing worldwide along with obesity-related disorders2,3. Much evidence indicated a linear association between BMI and risk of hypertension, type 2 diabetes, and CVD4,5. However, inconsistent or inverse associations between BMI and mortality in various population have resulted in the “obesity paradox”6–8. Several explanations for this paradox include survival or selection bias, treatment bias, or confounding effects of major risk factors9,10. On the other hand, some investigators have indicated the limitation of BMI as a true measure of obesity, as it does not differentiate between lean mass and fat mass and is thus limited by differences of body adiposity for a given BMI level across age, gender, and race11,12. In a meta-analysis that pooled 32 studies, BMI identified half of 32,000 individuals with excess body fat as normal13. Waist circumference (WC) has been proposed as a more accurate body adiposity index for the prediction of obesity-related disorders than BMI, because it has excellent correlations with abdominal fat imaging and high association with CVD risk factors and mortality14–17. However, WC is highly correlated with BMI, and is thus limited as an independent measure of BMI. Moreover, the phenomenon of obesity paradox has also been identified when obesity was measured by WC18. Another study has shown that high WC predicted increased mortality among patients with acute myocardial infarction only in consideration with BMI19. Other indices such as waist-to-height ratio (WHtR) and a body shape index (ABSI) defined by WC/(BMI2/3Height1/2) have been suggested as alternative indicators of obesity with some advantages than traditional indices. WHtR was better than BMI in association with diabetes and CVD risks20,21. ABSI is a new body shape index which has been developed based on WC divided by its regression fit on weight and height so that ABSI is minimally correlated with weight, height, and BMI. ABSI was found to be more closely associated with mortality risk than BMI and WC22. However, WHtR also had a strong correlation with BMI, thus, it was not free from the influence of BMI, and had a weaker association with mortality than BMI. In contrast, ABSI was uncorrelated with BMI, but several studies indicated that it is a less reliable indicator of cardiometabolic risk factors than BMI or WC23,24. Therefore, the limitations of traditional and newer anthropometric indicators suggest the need for an integrated adiposity index to have an ability to predict both cardiometabolic disease morbidity and mortality. We herein propose a new adiposity index termed the “weight-adjusted-waist index” (WWI) that is a standardized WC for weight, and aimed to validate the new index for the association with obesity-related disorders, cardiovascular mortality and all-cause mortality. METHODS Derivation of WWI We wanted an adiposity index representing waist circumference, having weak correlation with BMI to alleviate the obesity paradox of BMI for death, and having a negative correlation with height to differentiate the effect of height on the same waist. This could be accomplished by adjusting waist only for weight. When the BMI was first proposed, it was calculated by standardizing weight for height. Namely, the BMI was obtained by regressing the logarithm of weight on the logarithm of height to remove the effect of height on weight25 (the correlation between weight and height was 0.666, but that between BMI and height was as low as 0.072 in our data set). With the same concept, we proposed an index which standardizes waist circumference for body weight by the least squared regression of the logarithm-transformed WC on the logarithm-transformed weight as given by [formula: ln(WC)=β0+β1ln(weight)+ε.] The estimated β1 was 0.494 (p-value < 0.0001) that is close to 0.5. Thus, In(WC)−0.5In(weight)=1nwcweight lnwcweight became an estimate of β0+ε so that wcweight is almost uncorrelated with weight (the correlation was −0.025), by the characteristics of the least squared regression model24. We define the weight-adjusted-waist index (WWI) as wcweight whose mean values were 10.0 (±0.63) for males and 10.1 (±0.86) for females. Study population The Korean National Health Insurance Cohort (NHIS) study (2002–2013) is a population-based longitudinal study consisting of about one million Koreans, a representative 2.2% sample of the national population data. The NHIS data are composed of demographic information, anthropometric measures including body weight (kg) and height (m), medical and pharmacy records, health examination data, and death records. Annually, 10∼15% of the cohort population received health examinations. Since WC (cm) had been measured from 2008, our data-set included only the subjects who had ever undergone health examinations from 2008 to 2013. More detailed information has been given in previous publications6,26. The comparison of a new adiposity index with existing indices was done by model fit and predictive accuracy of incident cardiometabolic diseases including hypertension and type 2 diabetes and of cardiovascular and all-cause mortality. For the mortality prediction, we excluded subjects with pre-existing cancer or CVD before 2008 to avoid a possible confounding effect of those conditions on mortality. For each disease prediction, we also excluded those with corresponding preexisting diseases including hypertension, type 2 diabetes and CVD before 2008 when the specific disease was the risk of interest. For diagnostic data setting, among total 468,981 subjects, 5,105 subjects were additionally deleted for all-cause death and 354 subjects for CVD death due to missing information of explanatory variables. Accordingly, the total number of participants ranged from 425,917 to 465,627 depending on the study risks: 460,876 subjects with 5,469 deaths for all-cause death, 465,627 with 718 deaths for CVD death, 425,917 with 40,334 incidents in 2008 for hypertension, 442,532 with 23,808 incidents in 2008 for type 2 diabetes, 463,797 with 21,984 incidents in 2008 for CVD.

Read the complete text